Veracyte, Inc. (VCYT)
44.06
+2.59
(+6.25%)
USD |
NASDAQ |
Aug 25, 16:00
44.06
0.00 (0.00%)
After-Hours: 19:59
Veracyte Total Liabilities (Quarterly) : 97.96M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 97.96M |
| March 31, 2026 | 91.99M |
| December 31, 2025 | 127.64M |
| September 30, 2025 | 110.12M |
| June 30, 2025 | 123.05M |
| March 31, 2025 | 120.48M |
| December 31, 2024 | 158.05M |
| September 30, 2024 | 98.98M |
| June 30, 2024 | 101.80M |
| March 31, 2024 | 81.42M |
| December 31, 2023 | 93.72M |
| September 30, 2023 | 70.88M |
| June 30, 2023 | 78.40M |
| March 31, 2023 | 75.86M |
| December 31, 2022 | 113.44M |
| September 30, 2022 | 77.78M |
| June 30, 2022 | 80.05M |
| March 31, 2022 | 88.40M |
| December 31, 2021 | 128.57M |
| September 30, 2021 | 79.28M |
| June 30, 2021 | 56.26M |
| March 31, 2021 | 50.90M |
| December 31, 2020 | 35.93M |
| September 30, 2020 | 31.43M |
| June 30, 2020 | 30.59M |
| Date | Value |
|---|---|
| March 31, 2020 | 36.68M |
| December 31, 2019 | 35.76M |
| September 30, 2019 | 29.28M |
| June 30, 2019 | 28.14M |
| March 31, 2019 | 39.76M |
| December 31, 2018 | 40.88M |
| September 30, 2018 | 39.66M |
| June 30, 2018 | 39.66M |
| March 31, 2018 | 41.18M |
| December 31, 2017 | 41.44M |
| September 30, 2017 | 40.84M |
| June 30, 2017 | 40.50M |
| March 31, 2017 | 39.26M |
| December 31, 2016 | 41.45M |
| September 30, 2016 | 39.64M |
| June 30, 2016 | 41.08M |
| March 31, 2016 | 40.96M |
| December 31, 2015 | 24.03M |
| September 30, 2015 | 23.04M |
| June 30, 2015 | 17.42M |
| March 31, 2015 | 19.98M |
| December 31, 2014 | 23.46M |
| September 30, 2014 | 23.53M |
| June 30, 2014 | 22.72M |
| March 31, 2014 | 22.16M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Globus Medical, Inc. | 719.66M |
| Recursion Pharmaceuticals, Inc. | 297.66M |
| Anika Therapeutics, Inc. | 46.19M |
| Perspective Therapeutics, Inc. | 68.16M |
| Teleflex, Inc. | 3.882B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.486B |
| Shareholders Equity (Quarterly) | 1.388B |
| Debt to Equity Ratio | 0.0289 |
| Current Ratio | 9.162 |
| Net Debt Paydown Yield | 0.04% |